TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 35546060

Group type: EXPERIMENTAL
Intervention: Educational intervention for nursing staff on appropriate medication therapy and guidance to recognize potentially harmful medications and adverse effects
Number of subjects: 227

Group type: COMPARATOR
Intervention: No additional training for nursing staff (control group)
Number of subjects: 227
Study: 32956576

Group type: EXPERIMENTAL
Intervention: Delayed calcineurin inhibitor (CNI) substitution
Number of subjects: 225

Group type: COMPARATOR
Intervention: Standard of care (CNI-based)
Number of subjects: 225
Study: 32067132

Group type: EXPERIMENTAL
Intervention: Mnemonic strategy training (n=7), 3-day training, 45-60 minutes per session, focusing on encoding and retrieving information about objects and their locations using labeling, verbal reasoning, and mental imagery.
Number of subjects: 14

Group type: COMPARATOR
Intervention: Control group (n=7), received care as usual (occupational therapy, music therapy, and exercise).
Number of subjects: 14
Study: 32209728

Group type: EXPERIMENTAL
Intervention: Follitrope™ Prefilled Syringe
Number of subjects: 451

Group type: COMPARATOR
Intervention: Gonal‐F® Pen
Number of subjects: 451
Study: 36048113

Group type: EXPERIMENTAL
Intervention: Negative income shock narrative
Number of subjects: 140

Group type: EXPERIMENTAL
Intervention: Neutral income shock narrative
Number of subjects: 140

Group type: EXPERIMENTAL
Intervention: Positive income shock narrative
Number of subjects: 140

Group type: COMPARATOR
Intervention: Control (no income shock narrative)
Number of subjects: 140
Study: 33881716

Group type: EXPERIMENTAL
Intervention: Penetrating moxibustion
Number of subjects: 60

Group type: COMPARATOR
Intervention: Mild moxibustion
Number of subjects: 60
Study: 35501846

Group type: EXPERIMENTAL
Intervention: Video tele-education
Number of subjects: 378

Group type: EXPERIMENTAL
Intervention: In-person education
Number of subjects: 378

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 378
Study: 34406323

Group type: EXPERIMENTAL
Intervention: Skeletonized internal mammary artery graft harvesting
Number of subjects: 0

Group type: COMPARATOR
Intervention: Pedicled internal mammary artery graft harvesting
Number of subjects: 0
Study: 34391243

Group type: EXPERIMENTAL
Intervention: Kinesio Tape
Number of subjects: 42

Group type: COMPARATOR
Intervention: Sham Kinesio Tape
Number of subjects: 42
Study: 32026745

Group type: EXPERIMENTAL
Intervention: OnTrack-short (8 questions/survey)
Number of subjects: 121

Group type: EXPERIMENTAL
Intervention: OnTrack-long (17 questions/survey)
Number of subjects: 121
Study: 35753192

Group type: EXPERIMENTAL
Intervention: Online self-help intervention (two four-session trainings: cognitive training and motivational training)
Number of subjects: 77

Group type: EXPERIMENTAL
Intervention: Motivational training (second four-session training)
Number of subjects: 77
Study: 35645070

Group type: EXPERIMENTAL
Intervention: Piezocision procedure (Group II)
Number of subjects: 15

Group type: COMPARATOR
Intervention: Control group (Group I)
Number of subjects: 15
Study: 32608989

Group type: EXPERIMENTAL
Intervention: Integrated Approach of Yoga Therapy (IAYT), 3 classes per week for 12 weeks
Number of subjects: 66

Group type: COMPARATOR
Intervention: Standard care (control group)
Number of subjects: 66
Study: 34958771

Group type: EXPERIMENTAL
Intervention: Minimally Invasive (MI) approach
Number of subjects: 358

Group type: COMPARATOR
Intervention: Full Sternotomy (FS) approach
Number of subjects: 358
Study: 32868138

Group type: EXPERIMENTAL
Intervention: dd-MVAC
Number of subjects: 500

Group type: COMPARATOR
Intervention: GC
Number of subjects: 500
Study: 32246717

Group type: EXPERIMENTAL
Intervention: er-MedDiet + PA group
Number of subjects: 75

Group type: COMPARATOR
Intervention: MedDiet group
Number of subjects: 75
Study: 35913983

Group type: EXPERIMENTAL
Intervention: JEV vaccination (mouse brain-derived)
Number of subjects: 873

Group type: EXPERIMENTAL
Intervention: Living in peri-urban districts
Number of subjects: 873

Group type: EXPERIMENTAL
Intervention: History of prior dengue virus infection
Number of subjects: 873

Group type: EXPERIMENTAL
Intervention: Older age and male sex
Number of subjects: 873

Group type: EXPERIMENTAL
Intervention: Male sex
Number of subjects: 873
Study: 32281466

Group type: EXPERIMENTAL
Intervention: Multisensory perceptual training with fluoxetine (20 mg daily)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Multisensory perceptual training with placebo
Number of subjects: 20

Group type: COMPARATOR
Intervention: Fluoxetine (20 mg daily)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Multisensory perceptual training
Number of subjects: 20
Study: 34694154

Group type: EXPERIMENTAL
Intervention: Supine position (SUP)
Number of subjects: 112

Group type: COMPARATOR
Intervention: Prone position (PRO)
Number of subjects: 112
Study: 32791048

Group type: EXPERIMENTAL
Intervention: Sorafenib maintenance (400 mg orally twice daily)
Number of subjects: 202

Group type: COMPARATOR
Intervention: Control (non-maintenance)
Number of subjects: 202

Group type: EXPERIMENTAL
Intervention: Sorafenib maintenance
Number of subjects: 202
Study: 32588334

Group type: EXPERIMENTAL
Intervention: Dietary magnesium supplementation (2, 4, or 6 g/kg MgO)
Number of subjects: 120
Study: 35672956

Group type: EXPERIMENTAL
Intervention: Sustained specialist treatment (ST)
Number of subjects: 198

Group type: EXPERIMENTAL
Intervention: Sustained specialist treatment including Parent groups (ST + P)
Number of subjects: 198

Group type: COMPARATOR
Intervention: Treatment as usual (TAU)
Number of subjects: 198
Study: 34473834

Group type: COMPARATOR
Intervention: Control group in a stepped‐wedge randomised controlled trial
Number of subjects: 230

Group type: EXPERIMENTAL
Intervention: Previous hospital admission
Number of subjects: 230

Group type: EXPERIMENTAL
Intervention: More chronic diseases
Number of subjects: 230

Group type: EXPERIMENTAL
Intervention: Change in preference during follow-up
Number of subjects: 230
Study: 36351310

Group type: EXPERIMENTAL
Intervention: Dexmedetomidine-remifentanil
Number of subjects: 55

Group type: COMPARATOR
Intervention: Propofol-remifentanil
Number of subjects: 55
Study: 33472680

Group type: EXPERIMENTAL
Intervention: Semi-elemental formula
Number of subjects: 195

Group type: COMPARATOR
Intervention: Polymeric formula
Number of subjects: 195

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 195
Study: 32456512

Group type: EXPERIMENTAL
Intervention: Higher HDL-c variability
Number of subjects: 4428
Study: 35412432

Group type: EXPERIMENTAL
Intervention: Pain Neuroscience Education (PNE)
Number of subjects: 29

Group type: COMPARATOR
Intervention: Biomedical Education (BME)
Number of subjects: 29
Study: 33538192

Group type: EXPERIMENTAL
Intervention: Intervention group (patients from 17 PHCs in North Barcelona)
Number of subjects: 1932

Group type: COMPARATOR
Intervention: Control group (patients from 34 PHCs in South, East and West Barcelona)
Number of subjects: 1932

Group type: EXPERIMENTAL
Intervention: Intervention group
Number of subjects: 1932

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 1932
Study: 32449960

Group type: EXPERIMENTAL
Intervention: Granola labeled as 'Organic'
Number of subjects: 105

Group type: EXPERIMENTAL
Intervention: Granola labeled as 'Made with real grains'
Number of subjects: 105

Group type: EXPERIMENTAL
Intervention: Granola labeled as 'No preservatives'
Number of subjects: 105

Group type: EXPERIMENTAL
Intervention: Food choice and intake based on labels
Number of subjects: 105

Group type: EXPERIMENTAL
Intervention: Income level and age
Number of subjects: 105
Study: 36482530

Group type: EXPERIMENTAL
Intervention: TLE 400 (efavirenz 400 mg)
Number of subjects: 265

Group type: COMPARATOR
Intervention: TLE 600 (efavirenz 600 mg)
Number of subjects: 265
Study: 33471240

Group type: EXPERIMENTAL
Intervention: Tolvaptan
Number of subjects: 147
Study: 33175022

Group type: EXPERIMENTAL
Intervention: Motivational interviewing (3 consultations, 30-day intervals)
Number of subjects: 118

Group type: COMPARATOR
Intervention: Conventional follow-up in specialized clinics
Number of subjects: 118
Study: 34520849

Group type: EXPERIMENTAL
Intervention: RCTs focusing on education (33.9% of studies)
Number of subjects: 316
Study: 33549682

Group type: EXPERIMENTAL
Intervention: Computer-tailored intervention
Number of subjects: 693

Group type: COMPARATOR
Intervention: Non-tailored brochure
Number of subjects: 693
Study: 32664948

Group type: EXPERIMENTAL
Intervention: Extended 6-day course of artemether-lumefantrine and additional single low-dose primaquine (0.25 mg/kg) administered with the last dose.
Number of subjects: 195

Group type: COMPARATOR
Intervention: Standard weight-based 3-day course of artemether-lumefantrine.
Number of subjects: 195
Study: 33275794

Group type: EXPERIMENTAL
Intervention: iClearCyte algorithm
Number of subjects: 214

Group type: COMPARATOR
Intervention: ClearCyte® system with cytopathologist's review
Number of subjects: 214
Study: 32510985

Group type: EXPERIMENTAL
Intervention: PGA (fast polygluconate acid)
Number of subjects: 40

Group type: COMPARATOR
Intervention: PLLA (slow polylevolactic acid)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: PGA
Number of subjects: 40

Group type: COMPARATOR
Intervention: PLLA
Number of subjects: 40
Study: 35658345

Group type: EXPERIMENTAL
Intervention: PKU‐ML model (machine learning diagnostic model)
Number of subjects: 287

Group type: COMPARATOR
Intervention: Brock model (control)
Number of subjects: 287

Group type: COMPARATOR
Intervention: Mayo model (control)
Number of subjects: 287

Group type: COMPARATOR
Intervention: VA model (control)
Number of subjects: 287

Group type: COMPARATOR
Intervention: PKUPH model (control)
Number of subjects: 287
Study: 33819135

Group type: EXPERIMENTAL
Intervention: Cooling garment infused with cooled water (18°C) worn underneath FPC
Number of subjects: 12

Group type: COMPARATOR
Intervention: No cooling (control)
Number of subjects: 12
Study: 33835404

Group type: EXPERIMENTAL
Intervention: Sleep (12- or 24-hour delay with sleep)
Number of subjects: 115

Group type: COMPARATOR
Intervention: Wakefulness (12- or 24-hour delay without sleep)
Number of subjects: 115
Study: 34491443

Group type: EXPERIMENTAL
Intervention: Colored patient rooms
Number of subjects: 80

Group type: COMPARATOR
Intervention: Conventional patient rooms
Number of subjects: 80
Study: 34368923

Group type: EXPERIMENTAL
Intervention: Direct Sliding (DS) technique
Number of subjects: 36

Group type: COMPARATOR
Intervention: Power-arm Sliding (PAS) technique
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Both techniques
Number of subjects: 36
Study: 35725295

Group type: EXPERIMENTAL
Intervention: IST continuation
Number of subjects: 96

Group type: COMPARATOR
Intervention: IST discontinuation
Number of subjects: 96
Study: 32573912

Group type: EXPERIMENTAL
Intervention: Water-based exercise (WG)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Land-based exercise (LG)
Number of subjects: 0
Study: 35997713

Group type: EXPERIMENTAL
Intervention: Total Sleep Deprivation (TSD)
Number of subjects: 48
Study: 34347359

Group type: EXPERIMENTAL
Intervention: Prior metformin use
Number of subjects: 1290

Group type: EXPERIMENTAL
Intervention: Long-term metformin use
Number of subjects: 1290
Study: 32445077

Group type: EXPERIMENTAL
Intervention: Ketorolac (60 mg with 2% lignocaine)
Number of subjects: 67

Group type: COMPARATOR
Intervention: Methylprednisolone (40 mg with 2% lignocaine)
Number of subjects: 67

Group type: COMPARATOR
Intervention: Comparison between Ketorolac and Methylprednisolone
Number of subjects: 67
Study: 35256446

Group type: EXPERIMENTAL
Intervention: Acetazolamide 750 mg/day
Number of subjects: 40

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40
Study: 33594439

Group type: EXPERIMENTAL
Intervention: Hyperbaric oxygen therapy (HBOT) at 100% oxygen at 2.0 atmospheres per session, 5 days per week, for 8 weeks.
Number of subjects: 18

Group type: COMPARATOR
Intervention: Delayed treatment arm (control group) receiving HBOT after a 12-week waiting period.
Number of subjects: 18
Study: 36443093

Group type: EXPERIMENTAL
Intervention: Accelerated Partial Breast Irradiation (APBI) - 5× 6 Gy
Number of subjects: 57

Group type: COMPARATOR
Intervention: Accelerated Whole Breast Irradiation with boost - 15× 2.67 Gy + 5× 2 Gy
Number of subjects: 57

Group type: EXPERIMENTAL
Intervention: APBI
Number of subjects: 57
Study: 33503497

Group type: EXPERIMENTAL
Intervention: Cancer Prevention Wizard-Clinical Decision Support (CPW-CDS)
Number of subjects: 34

Group type: EXPERIMENTAL
Intervention: Cancer Prevention Wizard-Clinical Decision Support plus Shared Decision Making Tools (CPW + SDMTs)
Number of subjects: 34

Group type: COMPARATOR
Intervention: Usual Care (UC)
Number of subjects: 34

Group type: EXPERIMENTAL
Intervention: CPW-CDS and CPW + SDMTs
Number of subjects: 34
Study: 32650814

Group type: EXPERIMENTAL
Intervention: Oral hygiene instruction (OHI)
Number of subjects: 166

Group type: EXPERIMENTAL
Intervention: OHI, 6-month use of powered tooth brushing, and 0.2% chlorhexidine gluconate mouth rinse (10 ml twice daily)
Number of subjects: 166
Study: 34362422

Group type: EXPERIMENTAL
Intervention: Standard statistical analyses for truncated binary outcomes in small studies
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Increasing treatment effect on the intermediate variable
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Strength of confounding between the intermediate and outcome variables
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Presence of an interaction between treatment and confounder
Number of subjects: 0
Study: 32443139

Group type: EXPERIMENTAL
Intervention: Tramadol
Number of subjects: 76

Group type: COMPARATOR
Intervention: Codeine
Number of subjects: 76

Group type: EXPERIMENTAL
Intervention: CYP2D6 Genotyping
Number of subjects: 76
Study: 35061894

Group type: EXPERIMENTAL
Intervention: Empagliflozin (25 mg once daily)
Number of subjects: 34

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 34

Group type: EXPERIMENTAL
Intervention: Empagliflozin
Number of subjects: 34
Study: 33974725

Group type: EXPERIMENTAL
Intervention: Garlic powder supplementation (1,600 mg/d for 3 months)
Number of subjects: 90
Study: 33201504

Group type: EXPERIMENTAL
Intervention: Duration of using cosmetics
Number of subjects: 65

Group type: EXPERIMENTAL
Intervention: Age of participants
Number of subjects: 65
Study: 32680812

Group type: EXPERIMENTAL
Intervention: Manual lymphatic drainage (MLD), 6 sessions after surgery
Number of subjects: 26

Group type: COMPARATOR
Intervention: Control group (no MLD), same postoperative care as intervention group
Number of subjects: 26
Study: 33687748

Group type: EXPERIMENTAL
Intervention: Insulin glargine 300 U/mL (Gla‐300)
Number of subjects: 596

Group type: COMPARATOR
Intervention: Insulin degludec 100 U/mL (IDeg‐100)
Number of subjects: 596
Study: 36214350

Group type: EXPERIMENTAL
Intervention: Vertical Implantation of the Implantable Collamer Lens (ICL)
Number of subjects: 46

Group type: COMPARATOR
Intervention: Horizontal Implantation of the Implantable Collamer Lens (ICL)
Number of subjects: 46

Group type: EXPERIMENTAL
Intervention: Both Vertical and Horizontal Implantation of the ICL
Number of subjects: 46

Group type: EXPERIMENTAL
Intervention: Vertical Implantation of the ICL
Number of subjects: 46
Study: 34431170

Group type: EXPERIMENTAL
Intervention: Fingolimod 0.5 mg once daily
Number of subjects: 1556

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1556
Study: 32529467

Group type: EXPERIMENTAL
Intervention: Gossypol (20 mg once daily on days 1 to 14 every 21 days) combined with docetaxel (75 mg/m2) and cisplatin (75 mg/m2)
Number of subjects: 62

Group type: COMPARATOR
Intervention: Placebo combined with docetaxel (75 mg/m2) and cisplatin (75 mg/m2)
Number of subjects: 62
Study: 34479045

Group type: EXPERIMENTAL
Intervention: Intervention group (fruit and vegetable promotion activities for 7 months)
Number of subjects: 3414

Group type: COMPARATOR
Intervention: Control group (usual intervention: guided physical exercise 3 times/week)
Number of subjects: 3414
Study: 33852934

Group type: EXPERIMENTAL
Intervention: Advanced mode of the patient programmer
Number of subjects: 30

Group type: COMPARATOR
Intervention: Simple mode of the patient programmer
Number of subjects: 30
Study: 32869364

Group type: EXPERIMENTAL
Intervention: Combined potassium (39 K) and sodium (23 Na) MRI
Number of subjects: 10
Study: 33080655

Group type: COMPARATOR
Intervention: Sham disbudding
Number of subjects: 337

Group type: EXPERIMENTAL
Intervention: No anesthesia or pain medication
Number of subjects: 337

Group type: EXPERIMENTAL
Intervention: All treatments (sedation, local anesthesia, nonsteroidal antiinflammatory drugs)
Number of subjects: 337

Group type: EXPERIMENTAL
Intervention: Disbudding at an older age
Number of subjects: 337
Study: 33736863

Group type: EXPERIMENTAL
Intervention: 0.15% Triclosan
Number of subjects: 108

Group type: EXPERIMENTAL
Intervention: Denture cleaning tablets
Number of subjects: 108

Group type: EXPERIMENTAL
Intervention: Denture cleaning tablets plus gingival cleaning tablets
Number of subjects: 108

Group type: COMPARATOR
Intervention: 0.25% sodium hypochlorite
Number of subjects: 108

Group type: COMPARATOR
Intervention: Control group (0.25% sodium hypochlorite)
Number of subjects: 108
Study: 33278562

Group type: EXPERIMENTAL
Intervention: Females with anorexia nervosa (AN)
Number of subjects: 116

Group type: COMPARATOR
Intervention: Control group (females without an eating disorder or menstrual dysfunction)
Number of subjects: 116

Group type: EXPERIMENTAL
Intervention: Females with AN (elevated AMH)
Number of subjects: 116

Group type: EXPERIMENTAL
Intervention: Females with AN (normal AMH)
Number of subjects: 116
Study: 35144837

Group type: EXPERIMENTAL
Intervention: Tranexamic Acid (TXA) 1 g IV
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Tranexamic Acid (TXA)
Number of subjects: 45

Group type: COMPARATOR
Intervention: No Intervention (NTXA)
Number of subjects: 45
Study: 33757742

Group type: EXPERIMENTAL
Intervention: 3D-printed custom external nasal splint
Number of subjects: 40

Group type: COMPARATOR
Intervention: Thermoplastic external nasal splint
Number of subjects: 40
Study: 35771392

Group type: EXPERIMENTAL
Intervention: EORTC QLQ-C30 Global Health Status item
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: EORTC QLQ-C30 and QLQ-LC13
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Various psychometric methods
Number of subjects: 0
Study: 34024811

Group type: EXPERIMENTAL
Intervention: 5 breaths per minute (BPM)
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: 7 breaths per minute (BPM)
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: 4 breaths per minute (BPM)
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: 4 to 8 breaths per minute (BPM)
Number of subjects: 100
Study: 32676992

Group type: EXPERIMENTAL
Intervention: Artificial intelligence diagnostic model based on dynamic uncertain causality graph
Number of subjects: 202
Study: 36011774

Group type: EXPERIMENTAL
Intervention: Part-time worker dissemination
Number of subjects: 3995

Group type: EXPERIMENTAL
Intervention: Press release dissemination
Number of subjects: 3995

Group type: EXPERIMENTAL
Intervention: Official communication from the Swiss Federal Office of Public Health
Number of subjects: 3995
Study: 33232804

Group type: EXPERIMENTAL
Intervention: Colchicine (0.5 mg twice daily)
Number of subjects: 64

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 64
Study: 36099069

Group type: EXPERIMENTAL
Intervention: Saxagliptin + Metformin (Saxa + Met)
Number of subjects: 648

Group type: EXPERIMENTAL
Intervention: Saxagliptin + Acarbose (Saxa + Aca)
Number of subjects: 648

Group type: EXPERIMENTAL
Intervention: Saxagliptin + Gliclazide (Saxa + Gli)
Number of subjects: 648
Study: 34298547

Group type: EXPERIMENTAL
Intervention: A Healthy Start
Number of subjects: 364

Group type: EXPERIMENTAL
Intervention: Overall intervention
Number of subjects: 364
Study: 32716358

Group type: EXPERIMENTAL
Intervention: Polypharmacy (defined as taking five or more medications regularly)
Number of subjects: 514

Group type: EXPERIMENTAL
Intervention: Presence of diabetes
Number of subjects: 514

Group type: EXPERIMENTAL
Intervention: Presence of hyperlipidemia
Number of subjects: 514

Group type: EXPERIMENTAL
Intervention: Presence of both diabetes and hyperlipidemia
Number of subjects: 514

Group type: COMPARATOR
Intervention: Hypertension without diabetes or hyperlipidemia
Number of subjects: 514
Study: 32496365

Group type: EXPERIMENTAL
Intervention: Blood flow‐restricted resistance training (BFR‐RT) combined with aerobic training
Number of subjects: 24

Group type: COMPARATOR
Intervention: Aerobic training alone (control group)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Blood flow‐restricted resistance training (BFR‐RT)
Number of subjects: 24
Study: 32503251

Group type: EXPERIMENTAL
Intervention: Vitamin D status (measured as 25(OH)D levels)
Number of subjects: 302
Study: 34752723

Group type: EXPERIMENTAL
Intervention: Hyaluronic acid (HA) gel pulpotomy
Number of subjects: 44

Group type: COMPARATOR
Intervention: Formocresol (FC) pulpotomy
Number of subjects: 44

Group type: COMPARATOR
Intervention: Ferric sulphate (FS) pulpotomy
Number of subjects: 44
Study: 34098993

Group type: EXPERIMENTAL
Intervention: Chokeberry juice supplementation (200 ml per day for 7 weeks)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Control (placebo)
Number of subjects: 20
Study: 33969434

Group type: EXPERIMENTAL
Intervention: AT04A
Number of subjects: 72

Group type: EXPERIMENTAL
Intervention: AT06A
Number of subjects: 72

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 72
Study: 33263744

Group type: EXPERIMENTAL
Intervention: Rivaroxaban 2.5 mg twice daily plus 100 mg of aspirin once per day
Number of subjects: 0

Group type: COMPARATOR
Intervention: 100 mg of aspirin once per day
Number of subjects: 0
Study: 35751895

Group type: EXPERIMENTAL
Intervention: Hydraulic maxillary sinus lift without bone grafting
Number of subjects: 68

Group type: COMPARATOR
Intervention: Hydraulic maxillary sinus lift with bone grafting (Control)
Number of subjects: 68
Study: 33298013

Group type: EXPERIMENTAL
Intervention: Guideline concordant Standard Care (gcSC) with adjunct exercise treatment for 12 weeks
Number of subjects: 120

Group type: COMPARATOR
Intervention: Guideline concordant Standard Care (gcSC) alone
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Adjunct exercise treatment
Number of subjects: 120
Study: 36011639

Group type: EXPERIMENTAL
Intervention: Safe sex education module based on Social Cognitive Theory (SCT)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Conventional treatment provided in Seremban health clinics
Number of subjects: 0
Study: 33054794

Group type: EXPERIMENTAL
Intervention: 1000 IU/d vitamin D
Number of subjects: 84

Group type: EXPERIMENTAL
Intervention: 2000 IU/d vitamin D
Number of subjects: 84
Study: 35960720

Group type: EXPERIMENTAL
Intervention: Tocilizumab
Number of subjects: 354

Group type: COMPARATOR
Intervention: Standard care (including dexamethasone)
Number of subjects: 354